Nurix Therapeutics
NRIX
NRIX
130 hedge funds and large institutions have $508M invested in Nurix Therapeutics in 2023 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 45 increasing their positions, 38 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
2% more funds holding
Funds holding: 128 → 130 (+2)
9% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 23
Holders
130
Holding in Top 10
–
Calls
$575K
Puts
$61K
Top Buyers
| 1 | +$62.1M | |
| 2 | +$7.41M | |
| 3 | +$6.21M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$5M |
| 5 |
AAA
Affinity Asset Advisors
New York
|
+$4.54M |
Top Sellers
| 1 | -$9.63M | |
| 2 | -$8.8M | |
| 3 | -$8.41M | |
| 4 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$6.92M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$5.44M |